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Abstract. We report here that all trans-retinoic acid 
(RA), a classical morphogen, induces apoptosis during 
the neural differentiation of the embryonic stem cell 
line P19. The apoptotic cells showed, in addition to 
DNA cleavage, typical morphological changes includ- 
ing chromatin condensation, nuclear fragmentation, 
and cytoplasmic vacuolation. These apoptotic changes 
became obvious by 12 h after the addition of RA. The 
endogenous expression of bcl-2 in surviving cells was 
down-regulated during this process, and the compelled 
expression of bcl-2 by retroviral vectors reduced the 
number of apoptotic cells. Apoptosis was partially in- 
hibited by adding antisense oligonucleotides against 
RA receptors (RARs) simultaneously or by transfect- 
ing a plasmid vector flanked with a RA-responsive ele- 
ment. Antisense oligonucleotides against retinoid X re- 
ceptors (RXRs), the receptors for 9 cis-RA, did not 
inhibit apoptosis indUced by all trans-RA. Cyclohexi- 
mide and actinomycin D, inhibitors of protein and 
RNA syntheses, respectively, suppressed apoptosis. No 
changes were seen in the expression of tumor necrosis 
factors, their receptors, Fas, FasL, p53, or c-myc, mole- 
cules which have been suggested to participate in the 
apoptotic process. Addition of neurotrophins to the 
culture medium did not affect apoptosis. These findings 
suggest that the signals mediated by RARs, the differ- 
entiation signals themselves, promote expression of 
molecules essential for apoptosis. Furthermore, we ob- 
served that RA induced apoptosis of cerebral neurons 
from murine embryos in primary culture, which sug- 
gests that RA might participate in cell death which oc- 
curs during neural development. 
OPTOSIS  is  a  biological  process  which  causes  pro- 
grammed cell death during development and may 
participate in various pathological processes.  It is 
characterized by typical morphological changes including 
chromatin condensation, nuclear fragmentation, cytoplas- 
mic vacuolation, membrane blebbing  and cell shrinkage, 
as well as by the biochemical marker DNA cleavage. Apop- 
tosis  eliminates 20-80%  of neurons during development 
(Hamburger  and  Oppenheim,  1982; Oppenheim,  1991) 
but leaves neurons which are indispensable  for the func- 
tion of the nervous system. This process  seems  essential 
because unnecessary neurons might disturb the develop- 
ment of neural networks. The apoptotic process is also ob- 
served under conditions stressful  for neurons such as se- 
rum/neurotrophic factor deprivation (Greene and Tischer, 
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1976; Greene, 1978; Batistatou and Greene, 1991) or expo- 
sure to neurotoxins (Dispasquale  et al., 1991; Edwards et 
al., 1991) including toxic levels of glutamate (Kure et al., 
1991). Apoptosis has been postulated as a model for neu- 
ronal death in human neurodegenerative diseases because 
of morphological similarities at the cellular levels. 
Apoptosis is regulated by the balance of various mole- 
cules including tumor suppressor  genes, protooncogenes, 
and cell  cycle  regulators.  Among the tumor suppressor 
genes, Rb and p53 are known to participate in apoptosis. 
Inhibition of Rb  function by gene  disruption  (Morgen- 
besser et al., 1994) or by expression of human papiloma vi- 
rus protein E7 (Pan and Griep, 1994) interferes with ter- 
minal differentiation of lens fiber cells, causes apoptosis of 
those cells, and results  in micropthalmia. In this process, 
Rb acts as an inhibitor of DNA synthesis after withdrawal 
from the cell cycle and thereby prevent apoptosis.  On the 
other hand, disruption of the p53 gene in mice reduces 
apoptotic celt death (Clarke et al., 1993; Lowe et al., 1993). 
Over-expression  of p53 causes growth arrest and apoptosis 
(Yonish-Rouach  et  al.,  1991), and  p53  mutations  are 
widely observed in various  tumors (reviewed by Culotta 
and Koshland, 1993), suggesting that p53  mediates the 
apoptotic process  to suppress  the progression  of tumors. 
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fecting apoptosis  (Miyashita et  al.,  1994; Miyashita and 
Reed, 1995) such as c-myc (Askew et al., 1991; Evan et al., 
1992; Shi et al., 1992; Bissonnette et al., 1992; Fanidi et al., 
1992) and c-jun (Estus et al., 1994; Ham et al., 1995). 
bcl-2, a  protooncogene (Cleary and Sklar, 1985; Tsuji- 
moto et al.,  1985; Bakhshi et al.,  1985),  also affects the 
commitment to apoptosis (reviewed by White, 1994). The 
Bcl-2 protein forms heterodimers with other members of 
the bcl-2 gene family  including Bax (Oltvai et al., 1993), McM 
(Kozopos et al., 1993), A1 (Lin et al., 1993), Bcl-XL, Bcl-xs, 
(Boise et al.,  1993; Sato et al.,  1994),  Bad (Yang et al., 
1995), and Bak (Chittenden et al., 1995; Kiefer et al., 1995). 
BAG-l,  a  protein  nonhomologous  to  this  family,  also 
binds to Bcl-2 (Takayama et al., 1995). These partners de- 
termine whether the heterodimer acts as an inhibitor or 
promoter of apoptosis. Alterations in levels of reactive oxy- 
gen species (Hockenbery et al.,  1993; Kane et al.,  1993) 
and intracellular calcium (Bafy et al., 1993) by Bcl-2 have 
been  suggested  as  possible  anti-apoptosis  mechanisms, 
while there is evidence suggesting other mechanisms by 
which Bcl-2 can inhibit apoptosis (Shimizu et al., 1995). 
Molecules that determine the cell fate for apoptosis have 
been discovered, whereas the upstream and downstream 
apoptotic pathways that link initial stimuli to DNA frag- 
mentation have not yet been elucidated completely (re- 
viewed by Reed, 1994). 
To elucidate the specific features of neuronal apoptosis 
during development, an experimental system with which 
we can observe physiological stimuli inducing both neural 
differentiation and apoptosis is required.  Deprivation of 
trophic factors is commonly used for the analysis of neu- 
ronal apoptosis (Greene and Tischer, 1976), but this sys- 
tem is not so suitable for the investigation of differentia- 
tion. Here, we present an embryonic cell line, P19,  as a 
candidate system for the investigation of these processes. 
P19 is a widely used and well-documented system for the 
analysis of neural  differentiation, because  retinoic  acid 
(RA)  efficiently differentiates P19  cells to  neurons  and 
glias (Jones-Villeneuve et al., 1983; Rudnicki and McBur- 
ney, 1987; Staines et al.,  1994). We report here that: (a) 
RA induces apoptosis of P19 cells during the neural differ- 
entiation; (b)  bcl-2  expression is down-regulated during 
this apoptotic process; (c) apoptosis is inhibited by dysreg- 
ulated expression of Bcl-2 by retroviral infection; (d) the 
apoptotic signal is mediated by RA receptors  (RARs); 
(e) de novo induction of some genes by the RAR-medi- 
ated signal is necessary for apoptosis; (3') apoptosis is not 
directly affected by the cytokine systems which have been 
suggested to participate in cell death; and (g) apoptosis is 
induced  similarly in  embryonic neurons  by  RA.  These 
findings suggest  a  close  relationship  between  apoptotic 
signals and morphogenic signals and the possibility that 
the RA-induced apoptosis of P19 can be used as a model 
for the analysis of apoptosis during neural differentiation. 
Materials and Methods 
Cell Culture and RA Treatment 
P19  cells  were maintained in ct-MEM  (Sigma Chemical  Co.,  St.  Louis, 
MO) supplemented with 10%  fetal bovine serum (ICN Radiochemicals, 
Irvine, CA). To induce neural cell differentiation, 1 x  105 P19 cells were 
cultured in 10cm bacteriological dishes (Nipro) in 10 ml of medium con- 
taining 0.1 I~M of all trans-RA (Sigma Chemical Co., St. Louis, MO) for 4 d, 
transferred to tissue culture dishes (Coming, Coming, NY), and cultured 
in the absence of RA for 2 d. To induce mesodermal cell differentiation, 
they were cultured in tissue culture dishes for 2-4 d in the presence of RA. 
We used 10 -7 M RA in most experiments because this order of concentra- 
tion  is  commonly used  to differentiate  P19  (Rudnicki  and  McBurney, 
1987) and because it was optimal to observe apoptosis morphologically. 
However, RA concentrations were changed as described in the text and 
figure legends when necessary. RA stock solution (10  -4 M all trans-RA in 
ethanol) was diluted with the culture medium just before use. Cyclohex- 
imide and/or actinomycin-D at concentrations of 1.0 Ixg/ml and 0.1 p.g/ml, 
respectively,  were added for the inhibition of protein/RNA synthesis si- 
multaneously with RA. 
Ultrastructural  Analysis of Apoptotic Cells 
During the procedure for neural differentiation,  dying cells  were sepa- 
rated from cell aggregates. Culture medium was recovered to a centrifuge 
tube, and left to stand for 5 min. Cell aggregates dropped to the bottom 
during this time. The supematants were carefully removed to new centri- 
fuge tubes, and the floating cells were spun down at 200 g for 10 min. The 
collected  cells were prefixed with 2.5% glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.4), rinsed three times with 0.1 M phosphate buffer, postfixed 
in 1% OsO4 in 0.1 M phosphate buffer, and embedded in 1% agarose, de- 
hydrated, and re-embedded in Epon. Semi-thin sections were stained with 
0.1%  toluidine blue. Ultra-thin sections were contrasted with uranyl ace- 
tate and lead citrate. 
Estimation of Cell Death 
To calculate  the percentage cell death, we directly  counted the dead cells 
in preparations stained by trypan blue.  P19 cells  (1  ×  105/bacteriological 
dish in 10 ml of a  medium - 10%  FBS) or cultured neurons (the culture 
conditions were described later in Primary Culture of Neurons) were incu- 
bated with 10  -7 M of RA for 48 h. Thereafter they were scraped off from 
the bottom of the dishes and collected with the culture medium. An equal 
volume of 0.4%  trypan blue solution (GIBCO BRL, Gaithersburg, MD) 
was added to the medium and left for 1 rain. The numbers of stained and 
total cells were then counted within 5 rain. 
Immunohistochemical Analysis of Differentiated Cells 
Immunohistochemistry  was performed to determine the characteristics of 
the differentiated P19 and P19-Bcl-2 stable transformant cells. Antibodies 
against neurofilament 160K, GFAP, vimentin, GalC, and fibronectin were 
used for this purpose (Neural cell typing kit; Boehringer-Mannheim Bio- 
chemicals,  Indianapolis, IN). These cells  were fixed  with methanol pre- 
cooled to -20°C or 5% (vol/vol) acetic acid in ethanol in the case of stain- 
ing with the anti-GalC antibody. 
DNA Preparation and Analysis 
Genomic DNA was prepared as described previously (Okazawa et al., 
1991). Briefly,  dying cells were separated as described above and centri- 
fuged at 200 g for 10 min. The pellets were resuspended in a 10-fold vol- 
ume of RSB sulution (10 mM Tris-HCl, pH 7.4, 10 mM NaCl,  1.5  mM 
MgC12), left on ice for 10 min, homogenized in RSB with 0.5% NP-40, cen- 
trifuged at 800 g for 5 min. The resulting nuclear pellets were suspended in 
an equal volume of extraction buffer (50 mM Tris-HCl, pH 7.5, 100 mM 
NaCI, 100 mM EDTA) containing SDS (final 0.5%) and proteinase K (fi- 
nal 200 ng/ml), incubated at 37°C for 6 h, extracted with phenol/chloro- 
form (1:1) for more than 12 h, and centrifuged. The aqueous phase was re- 
covered, and dialyzed with TIE (10 mM Tris-HCl,  pH 7.5,1  mM NaEEDTA) 
for I d. The concentration of recovered DNA samples were checked, and 
1-p,g aliquots of each DNA sample were separated on 3% nucieve/agarose 
(3:1) gels. 
DNA Fragmentation  Assay 
This assay was performed according to the reported method (Sellins  and 
Cohen, 1987). 1 ×  106 cells were harvested by centrifugation at 200 g for 
10 min. The pellet was lysed with 0.4 ml hypotonic lysing buffer (10 mM 
Tris, 1 mM EDTA, pH 7.5)  containing 0.2%  Triton-X 100, and lysates 
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tin. The supernatent, containing fragmented DNA, was placed in a sepa- 
rate microfuge tube, and both pellet and supernatant were precipitated 
overnight at 4°C in 12.5% trichloroacetic acid. The percipitates were sedi- 
mented at 13,000 g for 10 min. The DNA in precipitates was hydrolyzed 
by heating 90°C for 10 min in 80 I~15% trichloroacetic acid, and 0.16 ml of 
DPA reagent (0.15 g diphenylamine, 0.15 ml sulfuric acid, 0.05 ml acetoal- 
dehyde in 10 ml glacial acetic acid; Sigma Chemical Co.) was added to 
each tube.  After overnight color  development, optical  densities of the 
samples were read at 600 nm. For the analysis of embryonic neurons in 
primary culture, 1 ×  105 cells were used for the reaction scaled down to 
1/10× vol. 
RNA Preparation and Northern Blotting Analysis 
RNA was prepared similarly to the step for separating nuclei. After cen- 
trifugation, Tris-HCl, pH 9.0 (final 100 mM), SDS (final 0.5%), and NaC1 
(final  100  mM), were  added to the supernatant followed by extraction 
with phenol/chloroform, and precipitation  with ethanol. Poly-A  ÷ RNA 
was separated by oligo-dT sepharose column chromatography (Pharmacia 
Fine Chemicals, Piscataway, NJ) according to the supplier's protocol. 20- 
I~g aliquots of each RNA sample were separated on 1% agarose gels in lx 
MOPS buffer (20 mM 3-[N-morpholino] propane-surphonic acid, 5 mM 
sodium acetate, pH 7.0,  1 mM Na2EDTA) containing 4% formaldehyde, 
and blotted onto Hybond N  (Amersham Corp., Arlington Heights, IL) 
with a vacuum blotter (Pharmacia Fine Chemicals). The filters were hy- 
bridized in 6× SSC, 5x Denhardt's solution, 1% SDS at 68°C and washed 
in 0.1×  SSC, 0.1%  SDS at 65°C.  The same filters were then hybridized 
with bcl-2-specific eDNA (from nucleotide 1833  to 2120;  Negrini et al., 
1987),  D1A dopamine receptor, and [3-actin (Takara) probes, which were 
radiolabeled with a  random primer labeling kit (Boehringer-Mannheim 
Biochemicals). The filters were then exposed for 7 d to Kodak XAR5 film. 
RT-PCR 
For the specific amplification of bcl-2 mRNA, we synthesized two primers 
based on the unique sequences of bcl-2 with no homology to the genes of 
other  family  members.  The  primers  used  were  5'-AAGAATTCGG- 
GAGAACAGGGTATG  (from 1832 to  1848 of the mouse bcl-2  gene, 
Negrini et al., 1987)  and 5'-AAGGATCCGGTAGCGACGAGAGA/(G 
(from 2137 to 2119). The expected size of the amplified product was 304 bp. 
The amplified products were digested and subcloned into pBluescriptSK  + 
between EcoRI and BamHI site. The primers for bax were CAGCTCT- 
GAACAGATCATG and GCCCATCTTCTTCCAGAT which amplified 
534  bp  (from  43  to  576  of the  mouse bax  gene;  Oltvai  et  al.,  1993; 
GenBank/EMBL/DDBJ  accession  number  L22472).  The  primers  for 
bad were CCAGGATCCAAATGGGAA and ATGTGGAGCAGAA- 
GATCA which amplified 651  bp  (from 460 to  1110  of the mouse bad 
gene;  Yang  et  al.,  1995;  GenBank/EMBL/DDBJ  accession  number 
L37296). The primers for bag-1 were CCGACAACATGGCCAAGA and 
TCCACTGCACTFCATTCA which amplified 679 bp (from 75 to 753 of 
the mouse bag-1 gene; Takayama et al., 1995; GenBank/EMBL/DDBJ ac- 
cession number U17162). For the amplification of G3PDH, c-myc, p53, 
TNF-tx, TNF-[3, TNFR-I, TNFR-II, Fas, and FasL transcripts, commercial 
primers purchased from Clontech (Palo Alto, CA) were used. Briefly, 200 
ng of total RNA, 0.1 p.M of both directional primers, 1× RT-PCR buffer 
consisting of 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 1.5 mM MgC12, 0.1 mg/ 
ml gelatin, 0.1%  Triton X-100, 0.25  mM dNTPs, 5  U  RNase inhibitor 
(Boehringer-Mannheim Biochemicals), 3.2 U AMV-reverse transcriptase 
XL  (Life  Science  Inc.,  Gaithersburg,  MD),  and  2  U  Taq  polymerase 
(Takara), were mixed in a  total volume of 25 p.1. The solution was incu- 
bated at 41°C for 30 min, denatured at 94°C for 3 min, and then used for 
PCR. The thermal cycle conditions were as follows: 94°C for 1 min, 55°C 
for 1 min, and 72°C for 1 min. Preliminary experiments were performed to 
determine the optimum thermal cycle number within the linear amplifica- 
tion range; 35 and 30 thermal cycles were performed for bcl-2  transcript 
and for the other gene transcripts, respectively. 
Retroviral Vector Construction and Production 
The human bcl-2 cDNA was subcloned into the pBC140 retroviral vector 
at the XhoI-cloning site (Shimizu et al., 1995).  This vector expresses the 
eDNA insert driven by the CMV promoter and the selectable marker neo- 
mycin phosphotransferase driven by the leukemia virus long terminal re- 
peat (LTR). Virus was generated from the recombinant retroviral vector 
plasmid pBC140B, pBC140B was transfected by calcium phosphate pre- 
cipitation into the if'2 packaging cell line. The transfected cells were se- 
lected with 800 ~.M G418. A  G418-resistant cell line, designated ~2/B4, 
was confirmed to produce viral particles sufficiently. P19 cells were trans- 
fected with supernatant from ~2/B4, selected with 300 ~M of G418 for 2 
wk. The expression of Bcl-2 in G418-resistant clones was tested by immu- 
noblot analysis. 
Construction and Transfection of  pRARE-CA  T 
Sense and antisense oligonucleotides corresponding to the RA response 
element (de-The et al., 1990) were synthesized, phosphorylated at their 5'- 
end, annealed and subcloned into pBLCAT2 (Luckow and Schutz, 1987) 
at  HindIII  sites.  The  sequences of  the  two  oligonucleotides were  5'- 
AGCTGGGTAGGGTFCACCGAAAGTrCACTCG (from -59 to -33 
of the RAR [3 gene; de-The et al.,  1990)  and 5'-AGCTCGAGTGAA- 
CTITCGGTGAACCCTACCC. After the plasmid was checked by se- 
quencing, it was amplified using a  Qiagen Maxi kit  (QIAGEN,  Chats- 
worth,  CA)  and  transfected  into  P19  cells  by  the  calcium phosphate 
method (Okamoto et al., 1990) using a Eukaryotic Transfection kit (Strat- 
agene Corp., La Jolla, CA). The P19 cells were treated with 15% glycerol 
in  I  x  BES  (25  mM  BES  [N,N-bis{2-hydroxyethyl}-2-aminoethane- 
sulfonic acid], 140 mM NaC1, 0.75 mM Na2HPO4-2H20), pH 6.96, 12 h af- 
ter the addition of plasmids. RA was added to the dishes 24 h after the ad- 
dition of DNA. Apoptotic cells were collected  according to a  protocol 
similar to that described in Estimation of Cell Death and counted by pho- 
tomicroscopy. 
Inhibition of  Apoptosis by Antisense Oligonucleotides 
Antisense and sense oligonucleotides were synthesized using an Applied 
Biosystems (Foster City, OR) nucleotide synthesizer, and purified by gel 
filtration. The sequences of antisense oligonucleotides were  as follows, 
RARM  :5 ' -ACTGCTATTGCTGGCCAT, RARer2:5  '-TTCCACACTCTC- 
GTACAT,  RAR[31/3:  5'-GTGGCTGCTGGTGCTCAT,  RAR[32:  5'- 
ATCCATACAGTCAAACAT, RARe: 5'-CTCCYFATI'GGTGGCCAT, 
retinoid X  receptor (RXR)ct: 5'-GAAATGTTTGGTGTCCAT, RXRI~: 
5'-AGTGGCGGGGGTGGCATr,  RXR~/:  5'-GGAATAATFFCCAT- 
ACAT. These sequences were  designed based on the previous reports 
(Zelent et al., 1989,  1991; Leroy et al., 1991; Mangelsdorf et al., 1992)  to 
overlap the initiation codons of receptors.  Sense oligonucleotides were 
made in the reverse orientations. Each oligonucleotide was added at 10 
p,M to the RA-containing culture medium and exchanged every 24 h. The 
optimal concentration was determined by preliminary experiments using 
various amounts of the oligonucleotides: 0.1,  1, 5, 10, and 20 p,M. The ef- 
fect on apoptosis reached a plateau at 20 p.M. Stability of the oligonucle- 
otides was checked before use. 10 p.M of each oligonucleotide radiola- 
beled with 3ZP--t-ATP and polynucleotide kinase (Toyobo, Tokyo, Japan) 
was incubated in a-MEM medium with 10% FBS at 37°C for 24 h. Degra- 
dation was estimated by polyacrylamide gel eleetrophoresis as described 
(Akhtar et al., 1991).  Percentage of the intact oligonucleotide band was 
calculated. The mean -+ SD made in 4 independent experiments was 32 _+ 
2% in RARer sense, 31 _+ 2% in RARM antisense, 33 +_ 2% in RARer2 
sense, 34 _+ 2% in RARtx2 antisense, 32 _+ 3% in RAR[31/3 sense, 30 _+ 
3% in RAR[31/3 antisense, 34 -+ 2% in RAR[32 sense, 30 +  2% in RAR[32 
antisense, 30 -  2% in RAR~ sense, 31  _+ 2% in RARe/antisense, 31 - 
2%  in RXRct sense, 33  _+  2%  in RXRct antisense, 32  _+  2%  in RXR[3 
sense, 33 -+ 2% in RXR[3 antisense, 30 -+ 2% in RXRy sense, and 34 "4- 
2% in RXR"¢ antisense. The stability was not statistically different among 
these oligonucleotides. 
Immunoblot Analysis 
For immunoblot analysis, G418-selected cells were isolated, amplified to 
confluency in 10 cm tissue dishes, and scraped into PBS (pH 7.4). The cells 
were collected by centrifugation at 200 g for 10 min, and the resulting pel- 
lets were suspended in ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 150 
mM NaC1, 5 mM EDTA, 1% Triton X-100) containing proteinase inhibi- 
tors.  After incubation on ice  for  10 min, samples were  centrifuged at 
15,000  g  for 20 min. Aliquots of Triton-soluble fractions (each  100  p~g) 
were subjected to SDS-PAGE,  blotted onto Hybond ECL (Amersham 
Corp.), and incubated with anti-human Bcl-2 monoclonal antibody (Santa 
Cruz), and then detected using an ECL-kit (Amersham Corp.). 
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Figure  L  (a)  DNA cleavage 
was  induced  by  RA  during 
the neural  differentiation of 
P19  cells  by  RA.  Genomic 
DNAs of dying cells were an- 
alyzed  on  3%  nusieve-aga- 
rose gels 48 h after RA treat- 
ment.  P19  cells,  cultured  in 
bacteriological dishes in  the 
presence  of  RA  at  various 
concentrations,  form  aggre- 
gates which differentiate into 
neural cells after being trans- 
ferred to tissue dishes (Rud- 
nicki  and  McBumey,  1987). 
During  this  process,  cells 
which lose their viability de- 
tach from the cell aggregates. 
These dying cells were sepa- 
rated,  and  their  genomic 
DNAs were analyzed. DNA 
cleavage  was  induced  by 
treatment with  10-9-10  -5  M 
RA  (lanes  4--8).  Only  a 
smear of RNA was observed 
at  RA concentrations below 
10 -9 M  (lanes 1-3).  (b)  Ob- 
servation  of  DNA  cleavage 
with  time.  10 -7  M  RA  was 
added to the culture medium and partial DNA cleavage was detected after 6 h (lane 1). The typical DNA ladder formation at 180 bp 
was firstly observed 12 h after the addition of RA (lane 2). DNA cleavage was attenuated after P19 cells were transferred to tissue cul- 
ture dishes and they ceased division and differentiated  into neurons (lanes 6 and 7). The medium was changed at each analysis to collect 
the cells that had newly lost viability between time points. (c) DNA fragmentation assay showing the rapid increase of DNA leakage 
from nuclei. When P19 cells were treated with 10 -9 or 10 -7 M RA but not with 10 -11 M RA, the percentage of DNA outside of nuclei, 
which was calculated as described in Materials and Methods, increased promptly. 
Primary Culture of  Neurons 
At first, the meninges were removed from the brain surface of El6 murine 
embryos. Small pieces of cerebral cortex (3 mmx 3 mm x  1 mm depth) 
were dissected from the cerebrum,  incubated in 0.25% trypsin (Immuno- 
Biological Laboratories)  at 37°C for 5 min, and dissociated by gentle pi- 
petting in Hank's Ca  2+, MgZ+-free  BSS (Sigma Chemical Co.) containing 
0.05% DNase I (Sigma Chemical Co.). Samples were then rinsed and re- 
suspended in a-medium (Sigma Chemical Co,) supplemented with 10% 
fetal  bovine  serum  (ICN  Radiochemicals)  and 5%  donor horse serum 
(CELLect; ICN Radiochemicals), and then seeded in poly-L-lysine  hydro- 
bromide (Sigma Chemical  Co.) -coated dishes. The same lots of serum 
were used for analysis. For the estimation of neuronal survival, we seeded 
1,000 neurons per single well in 16-chambers tissue slides (Corning). RA 
or oligonucleotides,  at  concentrations  described  in the figure  legends, 
were added to the medium as appropriate. 
Nick End-Labeling Method 
Nick end-labeling method was performed with a MEBSTAIN  Apoptosis 
kit (MBL) basically according to the commercial protocol. Cultured neu- 
rons were fixed by incubation  with precooled methanol at -20°C for 10 
min, washed with PBS three times, and incubated in 40 ~g/ml proteinase 
for 10 rain at 37°C. After washing with TdT buffer,  nicked  DNA ends 
were labeled with biotin-dUTP by terminal  deoxynucleotide  transferase. 
The enzymes and solutions used above were contained in the kit. The tis- 
sue slides were washed with water twice, incubated with avidin-peroxidase 
(Sigma Chemical  Co.), washed with PBS twice, and stained with DAB 
(3, 3'-diaminobenzidine;  Sigma Chemical Co.). 
Statistics 
InStat 2.0 computer software (Macintosh) was used for statistical analyses. 
Generally, multiple pair-wise comparisons were performed using analysis 
of variance and Bonferroni t test among groups of data. 
Results 
RA Induces Apoptosis during the Neural 
Differentiation of  P19 Cells 
P19 is one of the most commonly used embryonic cell lines 
for the analysis of differentiation as it possesses the char- 
acteristics of pluripotent stem cells  (Jones-Villeneuve et 
al.,  1983;  Rudnicki and McBurney, 1987), and differenti- 
ates into neurons and glial cells, when treated with RA in 
the  presence of cell-to-cell contact  (Jones-Villeneuve et 
al.,  1983; Rudnicki and McBurney, 1987).  The differenti- 
ated  P19  cells  express  various  neuronal  markers  like 
GABA,  GABA-transaminase,  glutamic acid decarboxyl- 
ase, neuropeptide Y, serotonin, DOPA decarboxylase, so- 
matostatin,  and  ionotropic glutamate  receptor (Ray and 
Gottlieb, 1994; Staines et al., 1994). RARs and RXRs have 
been proposed to mediate RA-induced signals  based on 
their abundant expression (Pratt et al.,  1990;  Bain et al., 
1994). 
We have noticed in previous experiments (Okamoto et 
al., 1990; Okazawa et al., 1991) that a large number of cells 
tend to die during the neural differentiation of P19 cells by 
RA, and we suspected this phenomenon may be apoptosis. 
The Journal of Cell Biology,  Volume 132, 1996  958 Figure 2.  Ultrastructure of dying P19 cells indicating apoptosis. P19 cells which lost their viability during RA-induced neural differenti- 
ation were collected and observed by electronmicroscopy.  Various phases of apoptosis were found in different cells (a). At higher mag- 
nifications, chromatin condensation (b), cytoplasmic vacuolation,  disruption  of the nuclear membrane, nuclear fragmentation (c), and 
rupture of the cytoplasmic membrane (d) were observed.  10  -7 M RA was used for the morphological  analysis presented here; however, 
we observed similar apoptotic changes on treatment with 10-9-10 -5 M RA. The percentage of apoptotic cells changed according to the 
concentration  of RA used. 
Firstly, to test this impression, genomic DNA of the dying 
cells was analyzed on  agarose gels on the  second day of 
RA treatment. As expected, DNA fragmentation at about 
180 bp was observed on  treatment with RA from 10  .9. 
10  .5 M  (Fig. 1 a). DNA fragmentation was confirmed by 
12 h after exposure to 10 .7 M RA (Fig. 1 b) and was atten- 
uated after day 5 when P19 cells ceased cell division and 
differentiated into neurons.  This observation was quanti- 
tatively confirmed by DNA fragmentation assay (Burton, 
1956;  Sellins  and  Cohen,  1987).  This  assay detected  the 
cellular change earlier than the agarose gel electrophoresis, 
because it observed the DNA leakage from nuclei (Fig. 1 c). 
Secondly,  the  ultrastructural  appearance  of the  dying 
cells was evaluated.  Almost all the  dying cells displayed 
typical apoptotic changes including  chromatin condensa- 
tion, nuclear fragmentation, and cytoplasmic vacuolation 
when treated with 10  .7 M RA (Fig. 2). The progression of 
apoptosis from the chromatin condensation to the rupture 
of the cytoplasmic membrane could be followed in differ- 
ent cells (Fig. 2). A  subpopulation of cells showed degen- 
erative changes when treated with a higher concentration 
of RA (data not shown). 
These morphological changes and the DNA fragmenta- 
tion were similarly induced by another form of RA treat- 
ment  that  evoked  differentiation  of P19  cells  predomi- 
nantly into endodermal cells. With this treatment, simply 
culturing P19 cells in tissue dishes for 2  d, apoptosis was 
observed within  12  h  with  RA  at  concentrations  above 
10 -1° M  (data not shown). This observation suggests that 
RA-induced apoptosis is not restricted to a specific orien- 
tation of differentiation. 
Apoptotic Signaling Pathway of RA 
All  trans-RA  binds  to  RARs,  while  9  cis-RA  binds  to 
RXRs and RARs  (for review see Chambon, 1994).  Both 
of these receptor families possess three members, et, [3, and 
~,  which  act  as  transcription  factors  when  activated  by 
their  ligands  (for review see  Mangelsdolf,  1994).  There- 
fore, it is possible that the RA-induced signal for the apop- 
tosis is similarly transduced to the nucleus by these recep- 
tors and  thereby elicits expression of genes which  cause 
apoptosis. 
To determine whether RARs mediate the apoptotic sig- 
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Figure 3.  Effects  of RARs antisense oligonucleotides on RA- 
induced apoptosis of P19 ceils. P19 cells were cultured in a-me- 
dium (Sigma Chemical Co.)  -10% FBS in the presence of 10  -7 
M of RA for 48 h. Percentage cell death was calculated by the 
formula (% number of trypan blue-positive cells from the exper- 
iment group  -  %  number of trypan blue-positive cells  back- 
ground)/(100 -  %  number of trypan blue-positive cells  back- 
ground). Addition of a  sense  or  an antisense oligonucleotide 
against an RAR family member did not affect the percentage cell 
death  significantly.  When  all  the  antisense  oligonucleotides 
against RARs were used in combination (a/13/'y = hhl, 10 ~M in 
total), the percentage cell death was repressed obviously, while 
combined use of the three antisense oligonucleotides (10 ixM in 
total) against RXRs did not reduce cell death efficiently.  Each 
bar represents the mean _+_  SD  of determinations made in 12 
fields from three separate cultures. *P <  0.01, **P <  0.05 com- 
pared with culture treated by RA but not oligonucleotides. 
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Figure 4.  Transfection with RA response element partially inhib- 
ited  RA-induced apoptosis.  Various amounts of the  pRARE- 
CAT plasmid (from 0.1-20 I~g of DNA/10 cm dish) were trans- 
fected into P19 cells by the calcium phosphate method. P19 cells 
were transferred to bacteriological dishes 24 h after transfection. 
Figure 5.  Effects of cycloheximide and actinomycin-D  on the apop- 
totic cell death evoked by RA. 1 X 105 P19 cells were seeded in 
bacteriological dishes. In addition to 10  -7 M RA, 1 ixg/ml cyclo- 
heximide (CHX) and/or 0.1 ~g/ml actinomycin-D (AMD) were 
added to the media, and trypan blue-positive cells were counted 
after 48 h. The percentage cell death was determined by the for- 
mula (% number  of trypan blue-positive  cells from the experiment 
group  -  %  number of trypan blue-positive cells  background)/ 
(100  -  %  number of trypan blue-positive cells  background). 
Each bar represents the mean +  SD of determinations made in 
12 separate fields  from three independent cultures. *P <  0.01 
compared to culture with RA alone. 
nal, we performed three sets of experiments. Firstly, we 
synthesized antisense oligonucleotides against RARs  (as 
well as RXRs) and observed whether they inhibited apop- 
tosis.  Oligonucleotides against  specific  members  of  the 
RAR family or against specific transcripts of an RAR fam- 
ily member reduced apoptotic cells mildly, while they ob- 
viously suppressed apoptosis with a statistical significance 
when used together (Fig. 3). As all the members of RAR 
and RXR families are expressed during the differentiation 
of P19  cells evoked by RA (Jonk et  al.,  1992; Bain and 
Gottlieb, 1994), these findings suggest that multiple mem- 
bers of the RAR family, but not of the RXR family for 9 
cis-RA,  participate  in  the  apoptotic  signal transduction 
from all trans-RA. 
Secondly, we transfected P19 cells with a CAT reporter 
plasmid  containing  RA  response  elements  (pRARE- 
They were cultured in the presence of 10 -7 M of RA for addi- 
tional 24 h  and trypan blue-positive cells were counted micro- 
scopically. CAT activities were assayed simultaneously  using an- 
other  dish  of P19  cells  treated  similarly.  The  percentage cell 
death was determined by the same formula as that shown in Fig. 
3. The relative CAT activity was a ratio to the mean value of the 
transfections using 5 Ixg of plasmid. The relationship between the 
percentage cell death and the relative CAT activity is shown in 
the figure. The negative relationship between these two parame- 
ters suggests that the RA response element absorbs the apoptotic 
signals mediated by some retinoic acid receptors. 
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Figure  6.  (a)  Expression  of 
bcl-2  was  not  detected  by 
Northern blot analysis during 
RA-induced neural differen- 
tiation of P19  cells.  PolyA  + 
RNA was prepared from dif- 
ferentiated P19 cells cultured 
in the  presence of RA  and 
undifferentiated  P19  cells 
cultured  in  the  absence  of 
RA.  Expression  of  the 
dopamine receptor D1A gene 
was  obviously  up-regulated 
in  differentiated  P19  cells, 
while expression of bcl-2 was 
not detected even when the 
x-ray film was exposed for 7 d. 
(b)  Expression of  bcl-2  was 
detected  by  RT-PCR  but 
suppressed  further  by  RA. 
P19  cells  were  cultured  in 
bacteriological dishes  in the 
presence or absence of 10 -7 M 
RA for 12 or 24 h. 1 Ixg of to- 
tal RNA was  used for each 
RT-PCR.  G3PDH  was  am- 
plified as  a  reference (lanes 
1, 2, 5, and 6). bcl-2 (lane 4 or 
8) was down-regulated obvi- 
ously when compared to  its 
reference (lane 3  or  7)  and 
G3PDH (lane 2 or 6) ampli- 
fied  from  the  same  RNA 
samples.  The  genes  corre- 
sponding to these bands were 
confirmed  by  sequencing 
analysis.  (c)  Quantitative 
analysis of bcl-2  expression. 
bcl-2  and  G3PDH  bands 
were quantified using an im- 
age analyzer. Percentage bcl-2 
amount  was  calculated  at 
each  time point by the  for- 
mula  (bcl-2  amount  in  the 
presence of RA  x  G3PDH 
amount  in  the  absence  of 
RA)l(bcl-2 amount in the ab- 
sence  of  RA  x  G3PDH 
amount  in  the  presence  of 
RA).  Values  represent  the 
mean _+ SD determined in triplicate experiments. *P < 0.01 compared to the value calculated with bcl-2 before treatment. (d) Expres- 
sion of the genes related to bcl-2 did not change during RA-induced neural differentiation. RNA samples were prepared from non-dif- 
ferentiated P19 cells or 24 h treatment with 10 -7 M RA and aggregation, bax, bad, and bag-1 gene expression was analyzed by RT-PCR. 
Specific bands for bad and bag-1 stayed constant (arrowheads). bax gene was not amplified in both conditions, while a nonspecific band 
was observed (dot). 
CAT) and observed its effect on apoptosis. We assumed 
that the transfected RA response element should compete 
for binding to RARs, with endogenous RA response ele- 
ments which  regulate the  genes inducing apoptosis,  and 
should  thereby  inhibit apoptosis.  Since  this  experiment 
was dependent on the transfection efficiency, we used the 
CAT activity as a marker for the efficiency and corrected 
the effect of pRARE-CAT on the RA-induced apoptosis. 
As expected, we observed an inverse correlation between 
the percentage cell death  and the CAT activity (Fig. 4). 
This result is consistent with the idea that RARs mediate 
the apoptotic signal of RA. Although the effect was less 
prominent as that of antisense oligonucleotides, this can 
be explained by the  difference in transfection efficiency 
between the two methods. 
Finally, we observed the effects of protein/RNA synthe- 
sis inhibitors on RA-induced apoptosis. We added cyclo- 
heximide for the inhibition  of protein synthesis and actino- 
mycin-D for the inhibition  of RNA synthesis to the culture 
media.  Numbers  of  apoptotic  cells  were  obviously de- 
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cell  lines  expressed  Bcl-2 
protein constitutively  during 
neural differentiation  evoked 
by RA. Protein samples were 
prepared from G418-selected 
cell lines  and P19 before or 
after RA treatment. 100  ~g/ 
lane of each sample was sep- 
arated on 6% SDS-polyacryl- 
amide gel and blotted onto a 
nylon  membrane which  was 
then  incubated  with  anti- 
human  Bcl-2  antibody.  The 
results  showed  that  G418- 
selected  cell  lines  expressed 
Bcl-2 protein in both undif- 
ferentiated  and  differenti- 
ated states. In contrast to this 
stable expression,  Bcl-2 pro- 
tein was not detected in the 
parental P19 celIs by immu- 
noblot analysis. (b) Bcl-2 par- 
tially  inhibited  RA-induced 
apoptosis  during  neural  dif- 
ferentiation.  Trypan  blue- 
positive  cells  were  counted 
48 h after addition of RA and 
the percentage cell death was determined by the formula shown 
in Fig. 3. The percentage cell death was lower in the cell lines 
constitutively  expressing Bcl-2 protein than in the parental P19 
ceils. 
creased by both treatments  (Fig.  5).  These observations 
suggest that RA-induced apoptosis requires de novo syn- 
thesis of causative gene products through transcriptional 
activation by RARs. 
bcl-2 Is Repressed Strictly during RA-induced 
Differentiation/Apoptosis 
bcl-2 expression was observed during the RA-induced dif- 
ferentiation for the following two reasons. Firstly, the im- 
portance  of Bcl-2  function  in  neuronal  death  has  been 
demonstrated  by  recent  studies.  Bcl-2  rescues  neurons 
from  the  programmed  cell  death  during  development 
(Garcia  et  al.,  1992),  and  inhibits  neuronal  apoptosis 
caused by neurotrophic factor deprivation (Allsopp et al., 
1993), serum deprivation (Mah et al., 1993), or exposure to 
multiple neurotoxic chemicals including glutamate (Zhong 
et al.,  1993; Reed, 1994).  Secondly, the expression of bcl-2 
in neurons was confirmed at the cellular level (Castren et 
al., 1994; Merry et al., 1994). 
We  performed  Northern  blot  analysis  using  polyA  ÷ 
RNA.  However,  neither  differentiated  nor  undifferenti- 
ated P19 cells expressed amounts of bcl-2 sufficient to be 
detected  by  this  procedure,  while  the  expression  of 
dopamine  receptor  D1A,  a  reference gene,  was up-regu- 
lated  during  differentiation  (Fig.  6  a).  Therefore,  we 
checked the expression of bcl-2 using RT-PCR.  Interest- 
ingly, bcl-2 transcript was further repressed by RA (Fig. 6 
b, lanes 3, 4,  7, and 8), while the housekeeping gene ex- 
pression of G3PDH estimated using the same RNA sam- 
ples was not changed (lanes 1 and 2). The down-regulation 
was obvious with a  statistical analysis of repeated experi- 
ments (Fig. 6 c). 
We  additionally  examined the  expression of genes re- 
lated to bcl-2: bax, bad, and bag-1. Bax has been shown to 
homodimerize as well as heterodimerize with Bcl-2 or Bcl- 
XL.  When  in  excess,  Bax  counters  the  action  of  Bcl-2 
(Oltvai  et  al.,  1993),  whereas  Bax  heterodimerizes  with 
Bcl-2 to repress apoptosis (Yin et al., 1994 ). Bad replaces 
Bax from Bcl-2-Bax or Bcl-xL-Bax heterodimers, increases 
homodimers of Bax, and promotes cell death (Yang et al., 
1995).  BAG-l,  although which is not homologous to the 
Bcl-2  family members, interacts  with  Bcl-2  and  repress 
apoptosis  (Takayama et al.,  1995).  RT-PCR analysis did 
not show obvious change in expression of these molecules 
(Fig.  6  d),  indicating  selective repression of bcl-2. These 
observations suggest that P19 cells are not sufficiently sup- 
ported  by the  bcl-2 homodimers  or  heterodimers  at  the 
critical period for their commitment to neuronal differen- 
tiation. 
bcl-2  expression  in  differentiated  P19  cells  was  not 
equivalent to that of neurons in adult rat reported previ- 
ously (Merry et al., 1994; Castren et al., 1994). As bcl-2 ex- 
pression is regulated developmentally (Merry et al., 1994; 
Castren et al., 1994;  Ferrer et al.,  1994),  this discrepancy 
could have been due to the difference in maturity between 
differentiated P19 cells and neurons in vivo. 
Dysregulated bcl-2 Expression Inhibits Apoptosis 
Induced by RA 
To test whether dysregulated bcl-2 expression can rescue 
P19 cells from RA-induced apoptosis, we established sta- 
ble transformants of P19 cells which express bcl-2 constitu- 
tively. P19 cells were transfected by a retroviral vector and 
selected  with  G418.  The  resultant  clones  (P19bc12-7, -8, 
and  -16)  were confirmed to express the  Bcl-2 protein  in 
both undifferentiated and differentiated states by Western 
blot analysis (Fig. 7 a) and to possess a similar differentia- 
tion potential to P19 cells by morphological and immuno- 
histochemical  analyses  (data  not  shown).  We  next  ob- 
served the  effects of dysregulated expression of bcl-2 on 
RA-induced apoptosis using these clones. The percentage 
cell death, which was estimated 48 h after addition of RA, 
was clearly repressed in  these  clones when compared to 
the parental cell line (Fig. 7 b). This suggested that bcl-2 
expression can partially inhibit RA-induced apoptosis. 
We  addressed  whether  P19bcl2s  and  P19  cells  could 
equally differentiate into neurons. When exposed to 10  -7 
RA in tissue culture dishes, P19bcl2s cells develop a small 
number of neurons on the layer of nonneuronal cells (Fig. 
8 a). When aggregated and exposed to 10  -7 RA in bacteri- 
ological dishes, they develop numerous neurons in subse- 
quent culture using tissue culture dishes (Fig. 8 b). These 
features  in  differentiation  were  similar  to  those  of  P19 
cells.  The  mean  percentages  of  differentiated  neurons 
were almost equal among the cell lines: 37% in P19, 36% 
in  P19bc12-7, 38%  in P19bc12-8, and  34%  in P19bc12-16, 
suggesting that the overexpression of bcl-2 did not directly 
influence on the differentiation potential of P19 cells. As a 
result, the number of differentiated neurons from P19bcl2s 
increased  correspondingly  to  the  reduction  of apoptosis 
(Fig. 8 c). 
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pressing bcl-2. 1 x  105 P19bc12-7 cells were cultured with 10 -7 M 
RA in a  10 cm tissue  grade culture dish for 4  d  (a)  or cultured 
with 10 -7 M  RA in a 10 cm bacteriological grade dish for 2 d and 
additionally in a 10 cm tissue grade dish for 2 d in the absence of 
RA (b).  Cells were incubated with a monoclonal anti-neurofila- 
ment 160K antibody (Boehringer-Mannheim) and detected by a 
biotinated secondary antibody and 3,3'-diaminobenzidine. In the 
former culture (a), small numbers of neurons extending neurites 
(arrowheads)  were  observed  on  the  non-neuronal  cell  layer. 
Large numbers  of neurons were differentiated in the latter cul- 
ture  (b).  (c)  Numbers  of  differentiated  neurons  increased  in 
P19bcl2s. P19  and P19bcl2s were differentiated by RA/aggrega- 
tion treatment as described in b. On day 4, the differentiated neu- 
rons were counted after immunostaining and the mean percent- 
age of neurons was determined in eight fields. Relative neuronal 
number was calculated by the formula: (total cell number of each 
P19bcl2  in  a  dish  ×  mean  percentage  of  neurons  in  each 
P19bcl2)/(total cell number of P19 in a dish  x  mean percentage 
of neurons  in P19).  Values  represent  the mean  +__  SD made in 
four independent cultures. 
Apoptosis Is Not Associated with Changes in 
Cytokine Expression 
It is possible to speculate that RA  causes apoptosis either 
by  repressing  signals  of neuroptrophins  or  by  enhancing 
apoptotic  signals  of some  cytokines.  With  regard  to  neu- 
rotrophic signals, the expression  of trkB, the receptor  for 
BDNF and NT-4/5, was shown to be increased during the 
neural  differentiation  of P19  cells by RT-PCR  (Salvatore 
Okazawa et al. Bcl-2 and Retinoic Acid-induced  Apoptosis  963 Figure 9.  RA-induced apoptosis of neurons from the murine embryonic brain. Embryonic neurons were prepared from the El6 cere- 
brum, incubated with trypsin, dispersed by gentle pipetting, and seeded in poly-L-lysine-coated dishes. They were then cultured in 
a-MEM medium containing 10% FBS and 5% horse serum in either the presence (b, d,f, and h) or absence (a, c, e, and g) of 10  -7 M RA 
for 2 d. Surviving cells were observed by phase-contrast microscopy (a-d), immunostained with anti-160K  neurofilament antibody (e 
and f), or labeled using a nick end-labeling (NEL) kit (g and h). Compared to non-treated neurons, the survival rate of RA-treated neu- 
rons was clearly lower (d). Their neurites were degenerated (f) and their nuclei were stained positively by NEL (h). 
et al., 1995; and our unpublished observation). Therefore, 
supplementing  the  culture  medium  with  neurotrophins 
should inhibit  apoptosis,  if neurotrophins  play an impor- 
tant role in RA-induced apoptosis. However this possibil- 
ity was excluded because addition of NGF, BDNF, NT-3, 
or NT-4 to the culture medium and the simultaneous use 
of all these neurotrophins had no effect on apoptosis (data 
not shown). We next analyzed the expression of molecules 
that have been suggested to participate  in cell death. RT- 
PCR  analysis  indicated  that  p53,  c-myc, TNF-receptor-I, 
and FasL expression were stable during RA-induced neu- 
ral  differentiation.  TNF-et,  TNF-[3, TNF-receptor  II, and 
Fas expression were hardly detected by this analysis (data 
not shown).  These  findings  do not support  the  idea  that 
apoptosis is a secondary phenomenon caused by a change 
in cytokine systems. 
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Figure 10.  (a) DNA cleavage 
observed in embryonic neu- 
rons treated with RA for 48 h. 
DNA  ladder  formation  was  *  P<o  .01 
seen in neurons treated with 
10 -9 or 10  -7 M RA (lane 3 or 
,0-'~  4) but not with 10  -11 M RA 
(lane 2). DNA from neurons 
cultured  in  the  absence  of 
~0-9  RA is shown as a  reference 
(lane 1).  (b) DNA fragmen- 
tation  assay  showing  the 
rapid increase of DNA leak- 
1~,~  age  from  nuclei.  When 
0 ~  treated with  10 -9  or  10 -7 M 
RA  but  not  with  10  -11  M 
RA, the percentage of DNA 
3  ,  9  12  outside  of  nuclei  increased 
.....  promptly. 
TNF-receptors I and II were reportedly up-regulated by 
RA in a neuroblastoma cell line (Chambaut-Guerin et al., 
1995). However, their data showed the down-regulation of 
TNF-receptor I  from days 4 to 6 and again the up-regula- 
tion from days 8  to 14, suggesting unstable  expression  of 
this  receptor.  The  up-regulation  of  TNF-receptor  II 
mRNA was observed only transiently on day 1. In our sys- 
tem using P19, the changes of TNF-receptors were not ob- 
served statistically. This discrepancy between the cell lines 
might reflect the difference in cellular maturity. 
RA Induces Apoptosis of  Embryonic Neurons in 
Primary Culture 
To test  whether  RA induces  neuronal  apoptosis in vivo, 
neurons  were  dissociated  from the  murine  cerebrum  at 
embryonic day 16 (E16).  Survival of these neurons in pri- 
mary culture was estimated 48 h  after dissociation, by di- 
rect cell counting under phase-contrast microscopy, by im- 
munostaining with anti-neurofilament  160K antibody, and 
by nick end labeling (NEL). 
The survival of neurons from the cerebrum of E16 em- 
bryos was decreased obviously by RA treatment  (Fig. 9). 
This neuronal death was judged to be apoptosis from the 
obvious nuclear staining shown by NEL experiments (Fig. 9) 
and the DNA fragmentation detected by agarose gel elec- 
trophoresis  (Fig.  10 a).  The quatitative  DNA fragmenta- 
tion  assay  confirmed  that  apoptosis  occurred  when  ex- 
posed to 10  -9 or 10 -7 M  RA (Fig. 10 b). A  slight increase 
in  the  percentage  DNA  fragmentation  of the  reference 
group was observed due to the inevitable death of primary 
neurons in culture  (Fig.  10 b). This finding corresponded 
to the observations  that  a  small portion of neurons mor- 
phologically died in the  absence of RA (Fig.  9)  and that 
the DNA of nontreated neurons showed a  faint smear in 
agarose gel  electrophoresis  (Fig.  10 a).  However,  it  was 
concluded undoubtedly that RA promoted apoptosis judg- 
ing from the DNA ladder formation in agarose gel electro- 
phoresis  and  the  substantial  increase  of  apoptosis  ob- 
served by DNA fragmentation assay (Fig. 10 b). 
Neurons  in primary culture  and  P19 cells  were  almost 
similar in the range of effective concentration of RA to in- 
duce apoptosis. RA-induced apoptosis of embryonic neu- 
rons in culture was similarly inhibited  by the use of anti- 
sense oligonucleotides against RARs (Fig.  11). Antisense 
oligonucleotides against RXRs were not capable to inhibit 
apoptosis  in  both  cases.  These  findings  suggest  that  P19 
cells and embryonic neurons used common signals in the 
RA-induced apoptosis. 
Discussion 
RA is one of the classical morphogens which induce cellu- 
lar  differentiation  and  participate  in  morphological  pat- 
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Figure 11.  Effects of antisense oligonucleotides against RARs on 
the  survival  of embryonic cerebral  neurons.  Neurons prepared 
from E16 murine cerebrum were cultured in conditioned medium 
containing 10% FBS and 5% horse serum. To induce apoptosis, 
10  -7 M of RA was added to the medium. Either 10 ixM of an oli- 
gonucleotide or 10 p~M of mixed oligonucleotides (ed13/7 =  1:1:1) 
was added to the medium. Survival and death of neurons were es- 
timated 48 h after cell dissociation by trypan blue staining.  Per- 
centage cell death was calculated as described in the legend for 
Fig.  3 to exclude natural  death during primary culture. Values 
represent the mean +_ SD of determinations made in 12 separate 
fields  from three independent cultures. There was a specific  re- 
duction of neuronal cell  death when antisense  oligonucleotides 
against RARs were used in combination. *P <  0.01 compared to 
culture with RA alone. 
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suspected to modulate or collaborate with the other mor- 
phogeneic signals such as the sonic hedgehog gene (Shh) 
(Echelard  et  al.,  1993; Riddle  et  al.,  1993),  homeobox 
genes (Morgan et al., 1992; Dolle et al., 1993; Charite et 
al., 1994), fibroblast growth factor 4 (FGF4) (Niswander et 
al., 1992, 1994), and bone morphogeneic proteins (BMPs) 
(Niswander et al., 1993; Francis et al., 1994) to function as 
a morphogen (reviewed by Maden 1994; Tabin, 1995). It is 
well known that apoptosis is induced at the inter-digital ar- 
eas during this limb formation. However, how RA contrib- 
utes to this process has not been determined. 
RA induces differentiation of various embryonic stem 
cell lines. P19 ceils are differentiated by RA into neuronal 
cells which express various neuron-specific molecules and 
display  typical  morphological  characteristics  (Rudnicki 
and McBurney et al., 1986). We found that apoptosis oc- 
curs during this neural differentiation. Our  experiments 
indicated that apoptosis was induced at least by 10 -9 M 
RA. It corresponds well to the minimum concentration of 
RA which efficiently activates RARs-mediated gene tran- 
scription (Zelent et al., 1989; Giguere et al., 1990).  Fur- 
thermore, our approaches inhibiting the RARs function 
succeeded in partially suppressing apoptosis. These find- 
ings suggest that RARs-mediated signal transduction play 
a major role in this apoptosis. RARs should regulate ex- 
pression of the genes affecting apoptosis as inhibitors of 
RNA/protein synthesis repressed the RA-induced apoptosis. 
Among the various molecules affecting apoptosis,  ex- 
pression of bcl-2 was selectively suppressed  during RA- 
induced apoptosis of P19 cells.  In addition, dysregulated 
expression of bcl-2 by a retroviral vector inhibited apopto- 
sis. However, the alteration of bcl-2 expression would not 
be  a  direct  cause  of apoptosis  because  undifferentiated 
P19 cells which show low levels of bcl-2 expression possess 
high viability. This suggests that the down-regulation of 
bcl-2 provides conditions where the RA-induced apoptosis 
can progress without difficulty. Further investigations are 
necessary to elucidate the  mechanisms which positively 
regulate RA-induced apoptosis. 
RA-induced  apoptosis  of  P19  cells  possesses  several 
unique characteristics: firstly, both neural differentiation 
and apoptosis progress simultaneously; secondly, apopto- 
sis is induced by a morphogen which possibly acts in vivo; 
and thirdly, this apoptosis is Bcl-2-repressible like the pro- 
grammed  cell  death  of neurons  in  vivo  (Garcia  et  al., 
1992). In these features, our system mimiked the apoptosis 
which occurs during neural differentiation. This similarity 
was further confirmed because RA actually induces apop- 
tosis of embryonic neurons. Meanwhile, it should be noted 
that the RA-induced apoptosis of P19 ceils differs from 
the  programmed  neuronal  death  seen  during  develop- 
ment; the apoptotic process begins immediately after the 
RA treatment when P19 cells have not yet displayed neu- 
ronal characteristics, and is attenuated after the differenti- 
ated P19 cells cease cell division. This is in contrast to the 
programmed neuronal death which occurs just after the 
arrival of their axons in the target field and therefore after 
partial maturation of neurons (reviewed by Barde, 1989). 
RA-induced apoptosis has been observed in other types 
of cells recently, and was first reported in HL-60 granulo- 
cytes (Park et al., 1994).  Interestingly, bcl-2 is repressed 
during differentiation of HL-60 by RA. Furthermore, dys- 
regulated expression of bcl-2 inhibits apoptosis similarly in 
HL-60 (Park et al., 1994). The second case has been re- 
ported in another embryonic carcinoma cell line, F9, dur- 
ing differentiation to visceral endodermal cells (Atencia et 
al., 1994). These observations suggest that RA could act as 
a ubiquitous signal triggering both apoptosis and differen- 
tiation in various tissues. 
The  natures  of  the  triggers  of  the  programmed  cell 
death which occurs in vivo during neural development are 
not  known.  We  suppose  that  RA  (or  other  retinoids) 
might act as an endogenous apoptotic signal during the de- 
velopment of the nervous system based on the following 
observations.  Firstly, RA  has  been  demonstrated to be 
present in the floor plate of the neural tube of embryos 
where apoptosis occurs during development (Hogan et al., 
1992). Secondly, the receptors for RAs, RARs and RXRs, 
as well as cellular retinol binding proteins (CRBPs) are ex- 
pressed widely throughout the nervous system during de- 
velopment (Maden et al., 1990; Ruberte et al., 1992, 1993; 
Dolle et al., 1994). Thirdly, the ability of low levels of RA 
to  trigger  apoptosis  during  the  neural  development  of 
stem cells was demonstrated in the present study. 
We also expect that our system will be useful for the 
identification of specific molecules that are indispensable 
for the apoptosis induced by steroid receptors. It is well 
known that glucocorticoids induce Bcl-2-repressible apop- 
tosis (Sentman et al., 1991; Strasser et al., 1991; Miyashita 
and Reed, 1992; Siegel et al., 1992).  Androgen receptor, 
when its CAG repeat is expanded, causes death of motor 
neurons  leading to  a  motor  neuron  disease  in  humans 
(LaSpada et al., 1991). These observations regarding ste- 
roid receptors and our present findings concerning RARs 
suggest that these receptors might share a common path- 
way of cell death especially in neurons. Analysis of the 
downstream signal transduction of the RA-induced apop- 
tosis  and  comparison  between  these  different  systems 
might be useful for understanding the general mechanism 
of neuronal death. 
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